Anesthesia was induced with 125 mg/kg ketamine and 5 mg/kg xylazine. Male PV-Cre and both male and female Ai6 mice were secured in a stereotaxic frame, and bilateral injections of 200–300 nl adeno-associated virus (AAV)1 vectors (AAV1-EF1a-DIO-ChETA-eYFP (catalog #26968, Addgene) to PV-Cre mice and pENN-AAV1-hSyn-Cre-WPRE-hGH (catalog #105553, Addgene) to Ai6 mice) were aimed with a 3 nl/s flow rate at the following coordinates from bregma (in cm): for BA injections, AP, −0.15; ML, 0.32–0.35; DV, 0.44–0.50; for midline thalamus injections, AP, −0.12–0.13; ML, next to the sinus; DV, 0.30–0.33; for lateral entorhinal cortex (LEnt) injections, AP, −0.42; ML, 0.375; DV, 0.28. After 4 weeks of recovery, mice were transcardially perfused with 4% PFA in 0.1 m PB for 30–40 min, and PFC sections were prepared as described above.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.